Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : GSLI Lumonics -- Ignore unavailable to you. Want to Upgrade?

To: BMcV who wrote (241)	7/7/2000 12:51:39 PM
From: sanford pepper	Read Replies (1) \| Respond to of 328

The excitement about the bioscan technology is misleading.<br> I am long on this stock but the equipment used in the scanning is undergoing tremendous changes in price, etc.<br> I agree the picks and shovels analogy is faulty here. What<br> you want to look for, and if you find it please tell me - are the public companies involved in disposables used in the process of scanning.

To: BMcV who wrote (241)	7/7/2000 9:27:49 PM
From: y3k	Read Replies (1) \| Respond to of 328

Bruce, The fact that a small fund 'took' a position in GSLI being small as it is merits some points. They have now increased their holdings of GSLI to 10,000 shares at an average cost of 39.85 (1 % of their portfolio). They have 74 stocks long in the portfolio with some good quality companies. And they have so far given returns of 87 % since inception on Aug 31, 1999. Not bad considering the market correction this spring. So if a lot of people follow this fund then it bodes well for GLSI. openfund.com A lot of people including yourself and Cheeky, analyst at RBC Dominion Securities think that the stock is fully valued. Needham and Co. has set a target of $36 and this target has now been exceeded. The CEO of GSLI Winston was reported selling most of his holdings in June 2 at $22.56 per share. VP Kurt sold about 1/5 of his holdings for $20 on June 1. IMHO the stock has been run up based on the prospect of the Optics division which had sales of $3 million last year. The Co. is projecting sales of $12 - $15 this year. Needham is projecting $25 - $30 million sales next year (very conservative) Needham is waiting for second Q results and review of company's new products before revising their target price. Maybe the market is also waiting. The Co. is in now quiet period. canadainvest.com Plus GSLI options trading starts next week (I think). I read that this is a plus for a stock. If only they would spin off the Optics division !! Hoping for a strong Q2 ! Long GSLI. Y3K